CinnoRA
Intensive drug therapy versus standard drug therapy for symptomatic intestinal Crohn’s disease strictures (STRIDENT) an open-label, single-centre, randomised controlled trial
Long-Term Outcomes With Adalimumab Therapy in Pediatric Crohn Disease Associations With Adalimumab Exposure
Cinnora_monograph
Intensive drug therapy versus standard drug therapy for symptomatic intestinal Crohn’s disease strictures (STRIDENT) an open-label, single-centre, randomised controlled trial
Long-Term Outcomes With Adalimumab Therapy in Pediatric Crohn Disease Associations With Adalimumab Exposure
CinnoRA Monograph